Key result
Glaucoma medication adherence rates vary widely across studies with differing assessment conditions precluding comparative analysis.
Why the study?
Adherence to pharmacological therapy is crucial to control glaucoma and prevent complications such as visual loss and irreversible blindness, making its evaluation important.
What are the medication adherence rates and how are they assessed in patients with glaucoma?
What are the medication adherence rates and how are they assessed in patients with glaucoma?
Adherence rates to glaucoma medication vary widely and are assessed using highly variable methods, highlighting the need for standardized assessment and improved health literacy.
Answers are grounded in this paper and cite their sources.
Adherence data in glaucoma warrant cautious interpretation due to inconsistent methods; leaves open the need for standardized assessment protocols in research.
Introduction: Glaucoma is an asymptomatic disease, which can cause irreversible blindness, with a worldwide prevalence around 64.3 million people. Adherence to glaucoma treatment is crucial to control the disease and to prevent its complications. Low medication adherence results in a visual loss, which can leads to irreversible blindness. In this sense it is important to know and evaluate adherence to pharmacological therapy among patients with glaucoma.Areas covered: A scoping review was conducted, according to the methodology proposed by Arksey and O’Malley. The databases used were Medical Literature Analysis and Retrieval System Online (MEDLINE) and the Biblioteca do Conhecimento Online (B-on). Our research used as primary sources articles in Portuguese and English.Expert opinion: The identified adherence rates were very different, and the conditions how under medication adherence was assessed were highly variable. These conditions impossibilities a proper comparative study. Further efforts are needed to increase health literacy and thus identify and support patients with low medication adherence rates. It is important that health care personnel could improve patients’ knowledge about the importance of medication adherence, glaucoma disease, and the consequences that result from the lack of treatment.
No takes yet. Share an insight, caveat, or question.
Rosu et al. (2020) conducted a review in Glaucoma. Medication therapy adherence was evaluated on Adherence rates and assessment conditions. Medication adherence rates in glaucoma were found to be highly variable across studies, with differing assessment conditions precluding proper comparative analysis.
Synapse has enriched 10 related papers. Consider them for comparative context: